AVIR vs TSLA · $353.7M cap vs P/E 179, rev $28.24B
Atea Pharmaceuticals Inc (AVIR) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Atea Pharmaceuticals Inc (AVIR) is a biotechnology company listed on US.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
AVIR does not have a complete income-statement cache yet.
Latest reported TSLA revenue for 2026-06-30 was $28.24B. Net income was $1.11B. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
AVIR currently screens at market cap $353.7M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the AVIR and TSLA stock pages for the full models.
Not investment advice.